21 September 2015 - The Committee for Medicinal Products for Human Use (CHMP) re-elected Dr Tomas Salmonson as its Chair at its September 2015 meeting. Dr Salmonson will serve a second three-year term beginning this month.

Accepting his re-election, Dr Salmonson said, “It is a great honour for me to receive the backing of my peers for another term. I have a deep respect and appreciation for the work of the dedicated and professional members of the Committee. CHMP is a forum for open discussion. Debate between members with different backgrounds and views is an essential element in delivering robust scientific opinions. I look forward to working even harder to maintain and strengthen this fruitful working environment in order to fulfil our public health mandate.”

Dr Salmonson (pictured) is Senior Scientific Advisor at the Swedish Medical Products AgencyExternal link icon, where he has worked since 1986. He has been a member of the CHMP for more than 15 years and has served as Chair of the Committee since September 2012.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/09/news_detail_002394.jsp&mid=WC0b01ac058004d5c1